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 1.  Do patients who have an ICD that is 
remotely monitored through a wireless 
Internet  based system on a monthly basis 
have a reduced heart failure admission rate 
and/or in-office visit as compared to 
quarterly face-to-face encounters for device 
interrogations? 
 
2.  Is there a lower level of anxiety in 
patients who have an ICD that was remotely  
monitored on a monthly basis for 6 months 
as compared to those who receive quarterly  
face-to-face encounters for device 
interrogations? 
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 Several studies have validated reducing heart    
    failure progression and readmission for HF by  
    maximizing pharmacologic intervention.  It will     
    increase quality of life in this population  
    and potentially be an efficient alternative as    
    compared to the present standard of quarterly  
    face-to-face office visits.   
 
 Patients should be educated on RM and also be  
    informed that RM is a tool to detect early  
    worsening of heart failure and may improve  
    clinical management and quality of life. 
 
 Arrhythmia clinics should consider the benefits  
   of monthly ICD interrogations for both their  
   patients and the community hospital regardless  
   of financial reimbursement.  
 
 Remote monitoring may improve overall patient  
    care and may ultimately reduce health care  
    costs.   
              Research Questions 
Background and Significance 
Heart failure (HF) patients undergo frequent 
visits to clinics and emergency rooms, have 
serious clinical implications and are a high 
economic burden to society.  In the US there 
are 400,000 to 700,000 newly diagnosed  HF 
patients annually.  
 
Remote Monitoring of ICDs can provide 
clinicians with early detection of impending 
critical  clinical issues.  Despite the research 
data favoring Remote Monitoring, 
organizational data is lacking regarding 
frequency to assess useful criteria, such as 
heart rate trends, activity level, fluid index 
and nightly heart rate.  It is unclear whether 
monthly measurements of these indicators 
will result in better clinical outcomes than 
quarterly measurements.  
       Inclusion Criteria:   
   Pts: with BiV-ICDs or ICDs for primary prevention  
           or secondary prevention 
   LVEF <35%, age 21 years or older 
   Speak English with NYHA for HF Class III-IV     
   Dx of ICM or NICM 
   Can provide informed  consent 
   Life expectancy greater than 1 year 
   Have an implanted Medtronic device with software     
          that can be transmitted wirelessly and have a     
          landline telephone  
      
      Exclusion Criteria:  
   Pts: awaiting heart transplant,  
   With left ventricular assist device   
   Who do not have a landline telephone 
                    
      Procedure 
   Based on the financial, logistical and time      
      constraints, the eligible members for this study was  
      limited to 35  patients    
 The research trial was a comparison study where 
the patients were randomly  assigned to one of two 
groups.  This design evaluated the impact of 
monthly remote monitoring on heart failure patients 
as compared to quarterly face-to-face encounters 
for device interrogations.  
 Following enrollment, each participant in each group 
was provided a set of questionnaires asking about 
demographics together with the Beck Anxiety 
Inventory questionnaire (BAI).  After 6 months, all 
participants were requested to retake the BAI. 
 The device diagnostics reviewed in the 
interrogations in months 1, 2, 3, 4, 5 and 6 or 
quarterly were six parameters:  the percentage of 
ventricular pacing, heart rate variability, average 
ventricular heart rate during the evening, the activity 
level in hours, the CareLink  OptiVol fluid trend, and 
the thoracic impedance trend. 
 There were no hospitalizations in the Quarterly     
group and there was one subject in the 
Monthly interrogation group who had 3 
hospitalizations, but the remaining subjects in 
that group did not have any hospitalizations. 
 There was not a significant difference between 
the Monthly Interrogation group and the 
Quarterly group with respect to the 
categorical variables.   
 Post-anxiety score and the Pre-anxiety score 
was analyzed separately for each group using 
the paired t-test.  There was a marginally non-
significant difference in the Monthly 
interrogation group (mean difference = 2.71, 
corresponding 95% confidence).  
 interval = [-0.025, 5.44], p<0.0519).   
 There was not a significant difference between 
the two groups across time for Opti Volume 
(p<0.0950). 
 There was not a significant difference 
between the two groups across time for Intra-
Thoracic Imp (p<0.6063 
  There was not a significant difference 
between the two groups across time for HRV 
(p<0.6875). 
  There was not a significant difference 
between the two groups across time for 
Percent Ventricular Pac (p<0.7457). 
 There was not a significant difference 
between the two groups across time for AVHR 
night (p<0.9685). 
 There was no significant difference between 
the Monthly Interrogation group and the 
Quarterly group across time (i.e. group*time 
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 Monthly RM of ICD devices may be an option for 
assessing and improving HF care, reducing 
interim visits, and decreasing the anxiety levels 
for patients with HF. 
 
 The time duration between remote monitoring 
needs to be verified by a large, multicenter, 
randomized clinical trial to determine the 
clinical potential of more frequent intervals of 
RM. 
 To compare rates between the monthly  
    remote control group and the quarterly   
    experimental group for emergency    
    department and unscheduled clinic visits. 
 
 To evaluate the impact of remote monitoring 
as a mechanism to reduce the anxiety level 
of patients with an ICD in both the control 
and experimental group. 
  Aims of the Study 
                        Statistical Analysis  
 Descriptive statistics (means ± standard 
deviations or medians and interquartile range 
[25th percentile, 75th percentile] for continuous 
data; frequencies and percentages for 
categorical data) were calculated by group 
(Monthly Interrogation vs. Quarterly).  
 
 The Fisher’s exact test was used to compare 
these two groups for the categorical variables 
in the questionnaire.  The Mann-Whitney test 
was used to compare these two groups for 
continuous variables (i.e. Anxiety Pre and 
Post).   
 
 Analysis of Covariance (ANCOVA) was used to 
test whether there is a difference in anxiety 
between the Monthly Interrogation group and 
the Quarterly group on the Post-Anxiety scores 
while controlling for Pre-Anxiety scores. Since 
the pre-score and the post-score are so highly 
correlated, the ANCOVA was used to "subtract 
out" or "remove” extraneous variability from 
the post-scores. 
 
